Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.
Rodday AM, Parsons SK, Upshaw JN, Friedberg JW, Gallamini A, Hawkes E, Hodgson D, Johnson P, Link BK, Mou E, Savage KJ, Zinzani PL, Maurer M, Evens AM. Rodday AM, et al. Among authors: mou e. J Clin Oncol. 2023 Apr 10;41(11):2076-2086. doi: 10.1200/JCO.22.02473. Epub 2022 Dec 10. J Clin Oncol. 2023. PMID: 36495588 Free PMC article.
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma.
Orellana-Noia VM, Isaac K, Malecek MK, Bartlett NL, Voorhees TJ, Grover NS, Hwang SR, Bennani NN, Hu R, Hill BT, Mou E, Advani RH, Carter J, David KA, Ballard HJ, Svoboda J, Churnetski MC, Magarelli G, Feldman TA, Cohen JB, Evens AM, Portell CA. Orellana-Noia VM, et al. Among authors: mou e. Blood Adv. 2021 Sep 28;5(18):3623-3632. doi: 10.1182/bloodadvances.2021004645. Blood Adv. 2021. PMID: 34448831 Free PMC article.
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.
Allen PB, Lu X, Chen Q, O'Shea K, Chmiel JS, Slonim LB, Sukhanova M, Savas H, Evens AM, Advani R, Pro B, Karmali R, Palmer B, Bayer RA, Eisner RM, Mou E, Dillehay G, Gordon LI, Winter JN. Allen PB, et al. Among authors: mou e. Blood Adv. 2023 Jun 27;7(12):2670-2676. doi: 10.1182/bloodadvances.2022008116. Blood Adv. 2023. PMID: 36083129 Free PMC article.
Corrigendum to: Global Cytopathology-Hematopathology Practice Trends.
Zadeh SL, Balassanian R, Cheung MC, Falchi L, Hasserjian R, Lin O, Long SR, Ly A, Menke JR, Mou E, Natkunam Y, Ruiz-Cordero R, Volaric AK, Wang L, Wen KW, Gratzinger D. Zadeh SL, et al. Among authors: mou e. Am J Clin Pathol. 2022 Jan 6;157(1):155. doi: 10.1093/ajcp/aqab184. Am J Clin Pathol. 2022. PMID: 34595513 Free PMC article. No abstract available.
Global Cytopathology-Hematopathology Practice Trends.
Zadeh SL, Balassanian R, Cheung MC, Falchi L, Hasserjian R, Lin O, Long SR, Ly A, Menke JR, Mou E, Natkunam Y, Ruiz-Cordero R, Volaric AK, Wang L, Wen KW, Gratzinger D. Zadeh SL, et al. Among authors: mou e. Am J Clin Pathol. 2022 Feb 3;157(2):196-201. doi: 10.1093/ajcp/aqab111. Am J Clin Pathol. 2022. PMID: 34508545 Free PMC article.
Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation.
Mou E, Falchi L, Sundaram V, Abramson JS, Balassanian R, Beygi S, Fitzpatrick MJ, Frank AK, Gupta S, Lin O, Reed JR, Long SR, Ly A, Menke JR, Reed DR, Ruiz-Cordero R, Volaric AK, Xie Y, Wang L, Wen KW, Zadeh SL, Natkunam Y, Cheung MC, Gratzinger D; Cyto-Heme Institutional Collaborative (CHIC) consortium. Mou E, et al. Leuk Lymphoma. 2021 Dec;62(12):2864-2872. doi: 10.1080/10428194.2021.1941936. Epub 2021 Jun 26. Leuk Lymphoma. 2021. PMID: 34176413
27 results